Survival with 2 DNA repair disorders - 13/02/13
Galia Ben-Zvi, MBBS, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, London, United Kingdom; A. Robson, MBChB, Department of Dermatopathology, St John's Institute of Dermatology, Guy's and St Thomas’ NHS Trust, London, UK, London, United Kingdom; Alan Lehmann, PhD, Genome Damage and Stability Center, University of Sussex, Falmer, Brighton, UK, London, United Kingdom; D. McGibbon, National Xeroderma Pigmentosum Service, and Department of Dermatopathology, St John's Institute of Dermatology, Guy's and St Thomas’ NHS Trust, London, London, United Kingdom; H. Fassihi, MBBS, MD, National Xeroderma Pigmentosum Service, and Department of Dermatopathology, St John's Institute of Dermatology, Guy's and St Thomas’ NHS Trust, London, London, United Kingdom; P. Norris, MBBS, Addenbrooke's Hospital, Cambridge University Hospitals NHS Trust, London, United Kingdom; RPE Sarkany, MBBS, National Xeroderma Pigmentosum Service, and Department of Dermatopathology, St John's Institute of Dermatology, Guy's and St Thomas’ NHS Trust, London, London, United Kingdom
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 68 - N° 4S1
P. AB100 - avril 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?